Cullinan Therapeutics (CGEM) Net Margin (2021)
Cullinan Therapeutics has reported Net Margin over the past 1 years, most recently at 7.49% for Q1 2021.
- Quarterly results put Net Margin at 7.49% for Q1 2021, changed N/A from a year ago — trailing twelve months through Dec 2021 was 356.25% (changed N/A YoY), and the annual figure for FY2021 was 356.25%, changed.
- Net Margin for Q1 2021 was 7.49% at Cullinan Therapeutics.
- Over the last five years, Net Margin for CGEM hit a ceiling of 7.49% in Q1 2021 and a floor of 7.49% in Q1 2021.